Side Effects and Treatment Discontinuation in Women Receiving Oral Iron Therapy: A Cross-Sectional Study
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Abs tractAim: Iron deficiency anemia remains a common global health problem, particularly affecting women owing to reproductive and nutritional factors.This study aims to assess the use of iron preparations, their side-effect profiles, and their impact on treatment adherence among women in Türkiye.Methods: This study was designed as a cross-sectional analytical study between October 1 and November 30, 2023.A total of 270 female patients receiving iron replacement therapy for at least one month were included in the study.A structured 20-item questionnaire was used to collect data on demographic characteristics, iron preparations, side effects, and treatment adherence.Data were analyzed using descriptive statistics, chi-square tests, t-tests, and binary logistic regression to identify predictors of treatment discontinuation.Results: Nausea was the most frequently reported cause of medication discontinuation (84.0%) and of switching (73.4%).Iron (III) polymaltose complex was associated with the highest rates of side effects (55.6% reported dyspeptic complaints) and treatment discontinuation (88.9%).The tablet formulation substantially increased the risk of treatment discontinuation by approximately ninefold overall and by about 5.6 fold due to side effects.Each additional year of age increased the odds of discontinuation by 10.4% (odds ratio 1.104; 95% confidence interval 1.062-1.146;p
Fields of Study & Subjects
Iron Metabolism and Disorders
Medication Adherence and Compliance
Hemoglobinopathies and Related Disorders
Publication details
- Journal / source
- Medical Bulletin of Haseki
- Volume
- 64
- Issue
- 3
- Publication date
- 31 March 2026
- Language
- EN